ArticleHeliyon2023

Development and evaluation of a novel chromium III-based compound for potential inhibition of emerging SARS-CoV-2 variants.

Yu-Jung Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.